DVAX
Dynavax Technologies Corporation
NASDAQ: DVAX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$15.50
+0.00% today
Updated 2026-02-11
Market cap
$1.82B
P/E ratio
—
P/S ratio
5.51x
EPS (TTM)
$-0.37
Dividend yield
—
52W range
$9 – $16
Volume
3.5M
Dynavax Technologies Corporation (DVAX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $80.09M | $102.89M | $120.45M | $90.62M | $50.47M | $84.25M | $134.10M | $139.75M | $204.62M | $138.29M | $216.63M | $109.68M | $218.78M | $210.88M | $279.07M | $353.27M | $1.04B | $985.85M | $997.10M | $986.26M |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $77.48M | $89.69M | $101.94M | $76.54M | $38.88M | $74.52M | $124.62M | $125.13M | $192.38M | $122.65M | $196.13M | $81.42M | $191.85M | $164.56M | $208.65M | $290.01M | $972.52M | $916.99M | $859.12M | $848.94M |
| Total liabilities | $5.73M | $23.82M | $81.32M | $74.47M | $44.09M | $32.14M | $34.22M | $24.93M | $18.33M | $37.81M | $29.55M | $20.48M | $19.24M | $147.82M | $270.78M | $294.58M | $816.87M | $404.84M | $375.02M | $389.46M |
| Current liabilities | $5.54M | $13.70M | $19.90M | $40.85M | $14.48M | $14.70M | $27.22M | $19.01M | $16.19M | $20.28M | $28.79M | $20.04M | $18.59M | $38.03M | $53.05M | $77.41M | $556.40M | $150.07M | $62.20M | $78.63M |
| Long-term debt | — | — | — | — | $9.34M | $10.94M | $0.00 | $0.00 | $0.00 | $9.56M | $0.00 | $0.00 | $0.00 | $100.87M | $178.60M | $179.81M | $220.49M | $221.58M | $222.70M | $223.85M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-115.89M | $-167.94M | $-227.91M | $-248.74M | $-259.64M | $-316.94M | $-365.54M | $-435.49M | $-502.21M | $-592.93M | $-699.73M | $-812.17M | $-907.33M | $-1.07B | $-1.22B | $-1.29B | $-1.22B | $-924.20M | $-930.58M | $-903.27M |
| Accounts receivable | $689000.00 | $2.15M | $7.23M | $6.41M | $895000.00 | $1.00M | $9.53M | $1.00M | $1.63M | $727000.00 | $1.39M | $1.34M | $854000.00 | $3.70M | $8.89M | $22.66M | $131.82M | $147.51M | $44.53M | $46.91M |
| Inventory | — | $257000.00 | $6.46M | — | — | — | $0.00 | $-3.06M | $0.00 | $-4.79M | $-3.82M | $-8.18M | $312000.00 | $19.02M | $41.33M | $63.69M | $61.34M | $59.45M | $53.29M | $70.05M |
| Goodwill | — | $2.31M | $2.31M | $2.31M | $2.31M | $2.31M | $2.31M | $2.48M | $2.58M | $2.28M | $2.04M | $1.97M | $2.24M | $2.14M | $2.08M | $2.30M | $2.13M | $2.01M | $2.07M | $1.95M |